Skip to content
★ Sign in to follow
MC

Matthew Campobasso

Executive
Enfusion, Inc.
Insider activity · 24 months0 buys3 salesCumulative net flow
Total declarations
15
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (8 ops.)
€67k

Latest filing published 21 Apr 2025 for Enfusion, Inc..

Filing timeline

BuySale
Matthew Campobasso

Insider track record

Disclosed buys
0
Disclosed sells
8
Signal history

Matthew Campobasso: trading record in brief

Matthew Campobasso discloses dealings in Enfusion, Inc. to SEC (Form 4). Over a trading history stretching from 8 January 2024 to 21 April 2025, the count stands at 15 filings.

Every open-market trade on record is a sale: 8 sales worth €67k. Besides market trades, the filings include 5 share grants. Since January 2025: no purchases and 3 sales on the market.

Most recently, on 21 April 2025, the filings show a transaction in Enfusion, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Matthew Campobasso

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations10 total
  • ●
    General CounselExecutivesEnfusion, Inc.
    0SEC
    25,147 sharesClass A Common StockSEC:0001104659-25-036900:0
  • ▼
    General CounselExecutivesEnfusion, Inc.
    19,281 USD32SEC
    1,695 shares@ US$11.37529.0% of flowClass A Common StockSEC:0001104659-25-021837:0
  • ▼
    General CounselExecutivesEnfusion, Inc.
    12,411 USD31SEC
    1,081 shares@ US$11.48119.0% of flowClass A Common StockSEC:0001104659-25-020991:0
  • ◆
    General CounselExecutivesEnfusion, Inc.
    0SEC
    17,637 shares0Class A Common StockSEC:0001104659-25-019134:0
  • ▼
    General CounselExecutivesEnfusion, Inc.
    9,887 USD31SEC
    976 shares@ US$10.1315.2% of flowClass A Common StockSEC:0001104659-25-002553:0
  • ▼
    General CounselExecutivesEnfusion, Inc.
    6,032 USD12SEC
    674 shares@ US$8.958.9% of flowClass A Common StockSEC:0001104659-24-111160:0
  • ▼
    General CounselExecutivesEnfusion, Inc.
    13,489 USD28SEC
    1,651 shares@ US$8.1720.1% of flowClass A Common StockSEC:0001104659-24-074025:0
  • ◆
    General CounselExecutivesEnfusion, Inc.
    0SEC
    23,069 shares0Class A Common StockSEC:0001104659-24-031186:0
  • ▼
    General CounselExecutivesEnfusion, Inc.
    943 USD23SEC
    108 shares@ US$8.731.4% of flowClass A Common StockSEC:0001104659-24-030622:0
  • ▼
    General CounselExecutivesEnfusion, Inc.
    4,357 USD30SEC
    472 shares@ US$9.236.4% of flowClass A Common StockSEC:0001104659-24-003081:0

10 of 10 declarations